NGP Polymers develops novel pharmaceutical polymers for improved drug formulations.
Active ingredients can do their job particularly well if they get to the right place in the body at the right time. To ensure this, the active ingredients are formulated with excipients to form highly efficient drugs. However, the selection of available polymeric excipients is limited. To expand this spectrum, Next Generation Pharma Polymers (NGP Polymers for short) develops, produces and markets novel polymer excipients for various applications in the pharmaceutical industry. Ulrich S. Schubert, co-founder of the Jena start-up, explains the background and goals of the company.